期刊文献+

西酞普兰对豚鼠心脏电活动的影响 被引量:2

Effects of citalopram on electrophysiological properties of cardiac myocytes
在线阅读 下载PDF
导出
摘要 目的研究抗抑郁药物西酞普兰对豚鼠心脏快、慢反应动作电位和离体及在体心电图的影响,初步探讨其引起心脏不良反应的机制。方法在整体动物、离体心脏和分离的心室乳头肌标本上分别采用肢体Ⅱ导联、Langendorff灌流技术和细胞内微电极技术记录豚鼠心电图、离体心电图和心室乳头肌快、慢反应动作电位。结果西酞普兰可明显延长豚鼠心电图的RR间期,使QRS波群增宽;离体心电图显示,西酞普兰能明显减慢心率,在12.5×10-6mol/L浓度灌流下,可诱发室性早搏及房室传导阻滞。在西酞普兰作用下,豚鼠心室乳头肌快反应动作电位的0期上升速率(Vm ax)的减慢、0期上升幅值(APA)的降低和时程(APD50和APD90)的缩短呈剂量依赖性;西酞普兰可浓度依赖性抑制异丙肾上腺素所诱发的豚鼠心室乳头肌慢反应动作电位。结论西酞普兰对心脏Na+、Ca2+等离子通道具有抑制作用,此效应可能是临床应用西酞普兰时出现心律失常等不良反应的离子基础。 Objective To investigate the influence of citalopram on the fast response action potential, slow response action potential, in vitro electrocardiogram (ECG) and in vivo ECG of cardiac myocytes, and explore its mechanism of adverse cardiac effects. Methods Conventional microelectrode technique was employed to record the fast and slow response action potentials of the isolated papillary muscles of guinea pigs. In vivo and in vitro ECG were recorded from anesthetized animals and Langendorff-perfused hearts, respectively. Results Citalopram could prolong the RR interval and QRS duration of in vivo ECG. The premature ventricular contraction and atrial ventricular block were induced by 12. 5 × 10^-6 mol/L citalopram. The maximum ascending velocity of 0 phase (Vmax), action potential amplitude (APA) and action potential duration (APD50 and APD50) were dose-dependently decreased by citalopram in the fast and slow response action potentials of guinea pigs, respectively. Conclusion Citalopram can inhibit sodium and calcium channels effectively, which may be the ionic mechanism that citalopram induces arrhythmia in the clinical practice.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第8期926-930,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委基金(06JC14045) 上海交通大学医学院基金(2008XJ003)~~
关键词 西酞普兰 快反应动作电位 慢反应动作电位 Langendorff灌流 离体心电图 豚鼠 citalopram fast response action potential slow response action potential Langendoff perfusion in vitro electrocardiogram guinea pig
  • 相关文献

参考文献18

  • 1Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns[ J] ? Curr Pharm Des, 2004, 10(20) : 2463 -2475.
  • 2De Ponti F, Poluzzi E, Cavalli A, et al. Safety of non-antiarrhythmie drugs that prolong the QT interval or induce torsade de pointes: an overview[ J]. Drug Saf, 2002, 25 (2) : 63 - 86.
  • 3Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death [ J]. Drugs, 2002, 62 ( 16 ) : 49 -71.
  • 4Witchel H J, Hancox JC, Nutt DJ. Psychotropic drugs, cardiac arrhythmia, and sudden death[ J]. J Clin Psychopharmacol, 2003, 23(1): 58-77.
  • 5Slavicek J, Pach I, Hamplova J, et al. Antidepressant drugs and heart electrical field [ J]. Physiol Res, 1998, 47 (7) : 297 -300.
  • 6Kanjanauthai S, Kanluen T, Chareonthaitawee P. Citalopram induced torsade de pointes, a rare life threatening side effect [ J ]. Int J Cardiol, 2008, 131(1): e33-e34.
  • 7Isbister GK, Friberg LE, Duffull SB. Application of pharmacokineticpharmacodynamic modelling in management of QT abnormalities after citalopram overdose [ J ]. Intensive Care Med, 2006, 32 (7) : 1060 - 1065.
  • 8Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses [J]. Br J Clin Pharmacol, 2006, 61(2) : 177 - 190.
  • 9Isbister GK, Bowe SJ, Dawson A, et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose [ J ]. J Toxicol Clin Toxicol, 2004, 42 (3) : 277 - 285.
  • 10De Ponti F, Poluzzi E, Cavalli A, et al. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview[J]. Drug Saf, 2002, 25(4): 263-286.

同被引文献45

  • 1王华阳,李华芳.新型抗抑郁药:米那普仑[J].中国新药与临床杂志,2006,25(5):384-388. 被引量:12
  • 2Ostr6m M, Eriksson A, Thorson J, et al. Fatal overdose with citalopram [J]. Lancet, 1996, 348 (9023): 339-340.
  • 3Grundemar L, Wohlfart B, Lagerstedt C, et al. Symptoms and signs of severe citalopram overdose [J]. Lancet, 1997, 349 (9065): 1602-1603.
  • 4Personne M, Persson H, SjOberg E. Citalopram toxicity [J]. Lancet, 1997, 350 (9076): 518-519.
  • 5Catalano G, Catalano MC, Epstein MA, et al. QTc interval prolongation associated with eitalopram overdose: a case re- port and literature review [J], Clin Neuropharmacol, 2001, 24 (3): 158-162.
  • 6Engebretsen KM, Harris CR, Wood JE. Cardiotoxicity and late onset seizures with citalopram overdose[J]. J Emerg Med, 2003, 25 (2): 163 -106.
  • 7Kanjanauthai S, Kanluen T, Chareonthaitawee P. Citalo- pram induced torsade de pointes, a rare life threatening side effect [J]. IntJ Cardiol, 2008, 131 (1): 33-34.
  • 8Tarabar AF, Hoffman RS, Nelson L. Citalopram overdose:late presentation of torsades de pointes (TdP) with cardiac arrest [J]. J Med Toxicol, 2008, 4 (2): 101-105.
  • 9de Gregorio C, Morabito G, Cerrito M, et al. Citalopram-in- duced long QT syndrome and torsade de pointes., role for con- comitant therapy and disease[J]. Int J Cardiol, 2011, 148 (2): 226-228.
  • 10Liotier J, Coudor6 F. Drug monitoring of a case of citalo- pram overdosage [J]. Drug Chem Toxicol, 2011, 34 (4) : 420-423.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部